Why Off-the-Shelf AI Falls Short in MedTech

Generic AI platforms rarely account for the risk classification, documentation, and lifecycle rigor that regulated devices demand. A model that misclassifies an image is an inconvenience in retail but a patient-safety event in healthcare. Custom development lets you control the training data provenance, model explainability, and validation evidence needed for regulatory submissions.

Bespoke solutions also align with your existing quality management system, so AI features are traceable to requirements, verified against acceptance criteria, and maintained under formal change control rather than bolted on as an opaque black box.

High-Impact AI Use Cases Across the Device Lifecycle

AI creates value from R&D through post-market surveillance. Manufacturers apply it to accelerate design, tighten production quality, and enrich the intelligence embedded inside the device itself.

• Software as a Medical Device (SaMD) for diagnostics and clinical decision support
• Computer vision defect detection on production and inspection lines
• Predictive maintenance for imaging systems and capital equipment
• Embedded AI firmware for real-time signal and image processing
• Adverse-event and complaint triage from post-market data
• Document AI for regulatory submissions, DHF, and technical files

Building AI Under IEC 62304 and a Regulated SDLC

Software feeding a medical device must be developed under a controlled software development lifecycle. We architect AI components to align with IEC 62304 software safety classification, ISO 13485 quality processes, and ISO 14971 risk management, producing the design history, verification, and validation records auditors expect.

This includes versioned datasets, reproducible training pipelines, and model documentation that captures intended use, performance boundaries, and known limitations, so every prediction can be traced back to controlled evidence.

Navigating FDA and Global Regulatory Pathways

AI/ML-enabled devices follow evolving guidance, including the FDA's Predetermined Change Control Plan for adaptive models and EU MDR expectations in Europe. Custom development anticipates these pathways by baking in transparency, bias evaluation, and human oversight from the first sprint rather than retrofitting them before submission.

Data Security, Privacy, and Interoperability

Connected devices generate protected health information that must be secured end to end. Our engineering enforces HIPAA and GDPR safeguards, encryption, and access controls, while HL7 FHIR and DICOM interoperability ensure your device integrates cleanly with hospital EHRs and imaging infrastructure.

Enterprise-Grade MLOps and Post-Market Monitoring

A compliant model is not finished at release. We stand up MLOps pipelines that monitor real-world performance, detect data drift, and manage validated retraining under change control. Continuous monitoring supports post-market surveillance obligations and keeps clinical performance aligned with the original intended use.

What Shapes Your Custom AI Investment

Every MedTech project is scoped differently, and several factors influence the effort involved rather than a fixed figure. Understanding these drivers helps you plan a realistic engagement with Sumeru Digital's team.

• Device risk class and required regulatory pathway
• Data readiness, labeling quality, and availability of clinical datasets
• Model complexity and explainability requirements
• Depth of validation, documentation, and audit evidence needed
• Integrations with EHR, PACS, and manufacturing systems
• Ongoing monitoring, retraining, and lifecycle support